{"id":7774,"date":"2026-08-29T11:33:06","date_gmt":"2026-08-29T09:33:06","guid":{"rendered":"https:\/\/mediconomics.com\/glossar\/human-factors-engineering-for-medical-devices\/"},"modified":"2026-08-29T11:33:06","modified_gmt":"2026-08-29T09:33:06","slug":"human-factors-engineering-for-medical-devices","status":"publish","type":"glossary","link":"https:\/\/mediconomics.com\/en\/glossar\/human-factors-engineering-for-medical-devices\/","title":{"rendered":"Human Factors Engineering for Medical Devices"},"content":{"rendered":"<p>Human Factors Engineering for medical devices refers to the engineering application of knowledge about human capabilities, limitations, and behavioral patterns to the design of products, user interfaces, accompanying documentation, and training. The goal is a design that fits the intended use, makes use errors unlikely, and limits their consequences. In international terminology, Human Factors Engineering and Usability Engineering are used largely synonymously; the US FDA uses the former term, while European standardization uses the latter. Regulation (EU) 2017\/745 does not use either term, but Annex I requires consideration of ergonomics, user knowledge, and the use environment, as well as the mitigation of risks resulting from use errors.   <\/p>\n<h2>Components of the Human Factors Process<\/h2>\n<p>The process begins with the description of the use context. This includes the user profile with qualifications, prior experience, sensory and motor requirements, as well as language and reading skills; the patient population; the use environment with light, noise, time pressure, distraction, and parallel device use; and the task sequence in the actual workflow. From this description, use scenarios are derived that map the expected sequence including preparation, use, error correction, cleaning, and disposal.  <\/p>\n<p>The use-related risk analysis builds upon this. It breaks down the scenarios into tasks, identifies potential use errors for each task, links them to hazards and severity of harm, and identifies critical tasks whose incorrect or omitted execution can lead to serious harm. This is followed by iterative design: design decisions are implemented in models and prototypes, tested with users, and then discarded or refined. Design-based measures are primarily effective, such as clear operating logic, error prevention through construction, feedback, and alarms; warnings and training are secondary means.   <\/p>\n<h2>Standards, Guidelines, and Documentation<\/h2>\n<p>The 2016 FDA guidance on applying Human Factors and Usability Engineering to medical devices describes the process in a result-oriented manner: it expects the identification of critical tasks, formative evaluations to uncover unexpected use errors, and a final validation test with representative users, the results of which allow for a root cause analysis. For validation, it generally recommends at least 15 participants per distinct user population and advises coordinating the test plan in advance as part of a pre-submission. <\/p>\n<p>Additionally, the ANSI\/AAMI HE75 standard serves as a reference work for the human-centered design of medical devices, providing specific design recommendations for displays, controls, alarms, labeling, software interfaces, and workstation design. It thus describes the &#8220;how&#8221; of design, while process-oriented requirements are located in international standardization. In the European context, it should be noted that the relevant usability standard is not listed as a harmonized standard in the Official Journal, so its application does not trigger a presumption of conformity under Article 8 of the Regulation; the legal reference points remain the general safety and performance requirements of Annex I.  <\/p>\n<h2>Distinction from Ergonomics, Design, and Risk Management<\/h2>\n<p>Human Factors Engineering is broader than classical ergonomics, which primarily considers physical fit, posture, and physical effort. It additionally encompasses cognitive aspects such as perception, attention, memory, consistency with expectations, and decision-making behavior under stress. It differs from creative product design through its focus on safety and the requirement for evidence: attractive user interfaces are not proof of safety as long as critical tasks have not been identified and tested.  <\/p>\n<p>Compared to risk management, Human Factors Engineering is not a parallel process but a specialized feeder discipline. It feeds use-related hazards into the risk analysis and adopts the evaluation criteria for the acceptance of residual risks from it. The process must also be separated from the summative validation testing itself: the process generates the design and the test items, while the study provides the evidence; the methodology for this is covered in the entry for Usability Studies for Medical Devices.  <\/p>\n<h2>Relevance for clinical trials<\/h2>\n<p>A robustly implemented Human Factors process improves the data quality of clinical trials because it reduces user errors as a source of interference before patient data is collected. It also provides the basis for determining which user groups must be represented in a trial, what training content is required for trial sites, and which user events must be defined as reportable so that product-related findings can be separated from use-related findings. <\/p>\n<p>Conversely, the clinical trial is a valuable source of observation for the process: deviations from the intended use, inquiries from trial sites, and anomalies in the documentation reveal design gaps that are then incorporated into labeling, instructions for use, and subsequent versions. Full-service CROs like Mediconomics support manufacturers in translating user profiles and use scenarios into trial and training documents and in feeding observations regarding use back into risk management and clinical evaluation in a structured manner. <\/p>\n<h2>Frequently Asked Questions (FAQ)<\/h2>\n<p><strong>Does the Regulation explicitly require Human Factors Engineering?<\/strong><\/p>\n<p>It does not use the term. However, Annex I requires consideration of ergonomics, user knowledge, and the use environment, as well as the mitigation of risks through use errors, which cannot be demonstrated without a systematic process. <\/p>\n<p><strong>What is a critical task?<\/strong><\/p>\n<p>A user task whose incorrect or omitted execution would or could lead to serious harm to patients or users. Critical tasks are derived from the use-related risk analysis and are fully tested in the validation study. <\/p>\n<p><strong>Are warnings sufficient as risk mitigation?<\/strong><\/p>\n<p>Only secondarily. Priority is given to design-based measures and technical protective measures; safety information, including warnings and training, is the final stage of the hierarchy of measures in Annex I. <\/p>\n<h2>Regulatory References<\/h2>\n<ul>\n<li>Regulation (EU) 2017\/745, Annex I Chapter I Sections 1 to 5 \u2013 Safety, ergonomics, user knowledge, and use errors.<\/li>\n<li>Regulation (EU) 2017\/745, Annex I Chapter III \u2013 Information in labeling and instructions for use as part of the design.<\/li>\n<li>FDA, Applying Human Factors and Usability Engineering to Medical Devices, 2016 \u2013 Process, critical tasks, validation testing.<\/li>\n<li>ANSI\/AAMI HE75 \u2013 Reference work for the human-centered design of medical devices.<\/li>\n<li>Regulation (EU) 2017\/745, Article 8 \u2013 Presumption of conformity only for harmonized standards listed in the Official Journal.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Human Factors Engineering for medical devices refers to the engineering application of knowledge about human capabilities, limitations, and behavioral patterns to the design of products, user interfaces, accompanying documentation, and training. The goal is a design that fits the intended use, makes use errors unlikely, and limits their consequences. In international terminology, Human Factors Engineering [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"glossary-cat":[24],"class_list":["post-7774","glossary","type-glossary","status-publish","hentry","glossary-cat-medizinprodukte-ivd"],"acf":[],"related_terms":"","external_url":"","internal_reference_id":"","_links":{"self":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/7774","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/users\/10"}],"version-history":[{"count":0,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/7774\/revisions"}],"wp:attachment":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/media?parent=7774"}],"wp:term":[{"taxonomy":"glossary-cat","embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary-cat?post=7774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}